Unbiased AI-powered news
Keith Thomas regained hand function and sensation through 2023 double neural bypass surgery. Researchers observed he retained strength and finger control after stimulation remained off for three months due to a building fire. New Scientist reported the findings suggest lasting neuroplasticity effects.
New ScientistKeith Thomas maintained the ability to move his hands and feel pressure after researchers turned off brain stimulation for three months, New Scientist reported. Thomas, 48, had been paralyzed from the chest down since a July 2020 diving accident and had no sensation or voluntary limb control.
In 2023 surgeons at the Feinstein Institutes for Medical Research implanted five electrodes in brain regions linked to arm movement and sensation.
Computer cables linked the electrodes to an AI system that decoded Thomas’s intended movements and sent signals to electronic splints on his arms, hands and fingers. Force sensors in 3D-printed wearables on his hands delivered pressure feedback through electrical stimulation to sensory areas of his brain. The team had planned to stop stimulation for one month to check for lingering effects.
A fire in the building extended the period without stimulation to about three months. After that interval Thomas retained strength, feeling and hand function, with improved individual finger control, New Scientist reported. Thomas raised his elbows nearly to shoulder level and reported a tingling sensation in his wrist when pressure was applied, even when disconnected from the computer system.
He also participated in experiments in which he felt objects through another person’s hand via the implant. Chad Bouton, a researcher at the Feinstein Institutes, said the team observed stronger neural responses in Thomas’s sensory cortex after the intervention. “We turned everything off completely, for many months, and yet he’s maintained these gains,” Bouton said.
Sergey Stavisky at the University of California, Davis, said the work indicates the approach can promote lasting recovery. Daniel Lu at the University of California, Los Angeles, noted the device may help the nervous system reorganize itself through neuroplasticity. Charles Greenspon at the University of Chicago said replication in more participants is needed before accepting broader claims.
Bouton said Thomas may continue to improve. The study appears in Nature Medicine.
Single source — no framing comparison available.
upi.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. Manufactured by Merck, the pill inhibits PCSK9 and cut LDL levels by up to 60 percent in a 24-week trial of 2,912 participants. It carries a list price of $315 for a 30-day supply and will reach…
washingtonpost.comAt least one person died and about 80 rescues occurred as the Guadalupe River rose 32 feet in four hours across central Texas. The flooding struck the same counties hit by deadly flash floods last summer.
flipboard.comEli Lilly will pay $2.8 billion in cash to acquire AtaiBeckley, a developer of psychedelic treatments for mental health conditions. The deal includes up to $1 billion in additional milestone payments. It adds the target’s compounds to Lilly’s neuroscience programs.